Literature DB >> 24372552

Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.

K Derakhchan1, R W Chui, D Stevens, W Gu, H M Vargas.   

Abstract

BACKGROUND AND
PURPOSE: During repeat-dose toxicity studies, ECGs are collected from chemically or physically-restrained animals over a short timeframe. This is problematic due to cardiovascular changes caused by manual restraint stress and anesthesia, and limited ECG sampling. These factors confound data interpretation, but may be overcome by using a non-invasive jacket-based ECG collection (JET). The current study investigated whether a jacketed external telemetry system could detect changes in cardiac intervals and heart rate in non-human primates (NHPs), previously implanted with a PCT transmitter. EXPERIMENTAL APPROACH: Twelve male cynomolgus monkeys were treated weekly with vehicle or sotalol (8, 16, 32 mg kg⁻¹) p.o. ECGs were collected continuously for 24 hours, following treatment, over 4 weeks. A satellite group of six NHPs was used for sotalol toxicokinetics. KEY
RESULTS: Sotalol attained Cmax values 1-3 hours after dosing, and exhibited dose-proportional exposure. In jacketed NHPs, sotalol dose-dependently increased QT/QTc intervals, prolonged PR interval, and reduced heart rate. Significant QTc prolongation of 27, 54 and 76 msec was detected by JET after 8, 16, and 32 mg kg⁻¹ sotalol, respectively, compared with time-matched vehicle-treated animals. Overall, JET-derived PR, QT, QTc intervals, QRS duration, and heart rate correlated well with those derived from PCT. CONCLUSIONS AND IMPLICATIONS: The current findings clearly support the use of JET to quantify cardiac interval and rhythm changes, capable of detecting QTc prolongation caused by sotalol. JET may be a preferred method compared to restraint-based ECG because high-density ECG sampling can be collected in unstressed conscious monkeys, over several weeks.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  Jacket telemetry; QT interval; cardiac repolarization; drug-induced QT prolongation; electrocardiogram; implanted telemetry; non-human primates; sotalol

Mesh:

Substances:

Year:  2014        PMID: 24372552      PMCID: PMC3904268          DOI: 10.1111/bph.12484

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Evaluation of blood pressure measurement using a miniature blood pressure transmitter with jacketed external telemetry in cynomolgus monkeys.

Authors:  Carrie McMahon; Andrea Z Mitchell; Jessica L Klein; Angela C Jenkins; R Dustan Sarazan
Journal:  J Pharmacol Toxicol Methods       Date:  2010-06-15       Impact factor: 1.950

4.  Cardiovascular function in nonclinical drug safety assessment: current issues and opportunities.

Authors:  R Dustan Sarazan; Scott Mittelstadt; Brian Guth; John Koerner; Joanne Zhang; Syril Pettit
Journal:  Int J Toxicol       Date:  2011-04-28       Impact factor: 2.032

Review 5.  Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals.

Authors:  Hugo M Vargas; Hamid R Amouzadeh; Michael J Engwall
Journal:  Expert Opin Drug Saf       Date:  2012-11-21       Impact factor: 4.250

6.  Integration of safety pharmacology endpoints into toxicology studies.

Authors:  Jörg Luft; Gerd Bode
Journal:  Fundam Clin Pharmacol       Date:  2002-04       Impact factor: 2.748

7.  Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.

Authors:  Alan S Bass; Laurie A Hanson; Terry A Jackson
Journal:  J Pharmacol Toxicol Methods       Date:  2009-05-14       Impact factor: 1.950

Review 8.  Integrated risk assessment and predictive value to humans of non-clinical repolarization assays.

Authors:  Robert M Wallis
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.

Authors:  Helen Prior; Nick McMahon; Jason Schofield; Jean-Pierre Valentin
Journal:  J Pharmacol Toxicol Methods       Date:  2009-06-16       Impact factor: 1.950

10.  Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.

Authors:  Ray W Chui; Abigail Fosdick; Ra'Shun Conner; Jian Jiang; Bernd A Bruenner; Hugo M Vargas
Journal:  J Pharmacol Toxicol Methods       Date:  2009-05-05       Impact factor: 1.950

View more
  6 in total

1.  Smart undershirt.

Authors:  Teresa Woodger
Journal:  Lab Anim (NY)       Date:  2017-10-06       Impact factor: 12.625

2.  Social housing of non-rodents during cardiovascular recordings in safety pharmacology and toxicology studies.

Authors:  Helen Prior; Anna Bottomley; Pascal Champéroux; Jason Cordes; Eric Delpy; Noel Dybdal; Nick Edmunds; Mike Engwall; Mike Foley; Michael Hoffmann; Robert Kaiser; Ken Meecham; Stéphane Milano; Aileen Milne; Rick Nelson; Brian Roche; Jean-Pierre Valentin; Gemma Ward; Kathryn Chapman
Journal:  J Pharmacol Toxicol Methods       Date:  2016-03-31       Impact factor: 1.950

3.  Using imaging photoplethysmography for heart rate estimation in non-human primates.

Authors:  Anton M Unakafov; Sebastian Möller; Igor Kagan; Alexander Gail; Stefan Treue; Fred Wolf
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

4.  Automated video-based heart rate tracking for the anesthetized and behaving monkey.

Authors:  Mathilda Froesel; Quentin Goudard; Marc Hauser; Maëva Gacoin; Suliann Ben Hamed
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

Review 5.  Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective.

Authors:  Hugo M Vargas; Michael G Rolf; Todd A Wisialowski; William Achanzar; Anthony Bahinski; Alan Bass; Charles T Benson; Khuram W Chaudhary; Nicolas Couvreur; Corina Dota; Michael J Engwall; C Michael Foley; David Gallacher; Andrea Greiter-Wilke; Jean-Michel Guillon; Brian Guth; Herbert M Himmel; Christa Hegele-Hartung; Maki Ito; Stephen Jenkinson; Katsuyoshi Chiba; Armando Lagrutta; Paul Levesque; Eric Martel; Yoshiko Okai; Ravikumar Peri; Amy Pointon; Yusheng Qu; Ard Teisman; Martin Traebert; Takashi Yoshinaga; Gary A Gintant; Derek J Leishman; Jean-Pierre Valentin
Journal:  Clin Pharmacol Ther       Date:  2020-09-24       Impact factor: 6.875

6.  Evaluation of moxifloxacin in canine and non-human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration-QTc analysis.

Authors:  Ray W Chui; Joel Baublits; Fiona A Chandra; Zack W Jones; Michael J Engwall; Hugo M Vargas
Journal:  Clin Transl Sci       Date:  2021-07-14       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.